Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors

dc.contributor.authorVenugopal, P.P.
dc.contributor.authorDas, B.K.
dc.contributor.authorSoorya, E.
dc.contributor.authorChakraborty, D.
dc.date.accessioned2026-02-05T09:28:58Z
dc.date.issued2020
dc.description.abstractG-protein coupled glucagon receptors (GCGRs) play an important role in glucose homeostasis and pathophysiology of Type-II Diabetes Mellitus (T2DM). The allosteric pocket located at the trans-membrane domain of GCGR consists of hydrophobic (TM5) and hydrophilic (TM7) units. Hydrophobic interactions with the amino acid residues present at TM5, found to facilitate the favorable orientation of antagonist at GCGR allosteric pocket. A statistically robust and highly predictive 3D-QSAR model was developed using 58 ?-alanine based GCGR antagonists with significant variation in structure and potency profile. The correlation coefficient (R2) and cross-validation coefficient (Q2) of the developed model were found to be 0.9981 and 0.8253, respectively at the PLS factor of 8. The analysis of the favorable and unfavorable contribution of different structural features on the glucagon receptor antagonists was done by 3D-QSAR contour plots. Hydrophobic and hydrogen bonding interactions are found to be main dominating non-bonding interactions in docking studies. Presence of highest occupied molecular orbital (HOMO) in the polar part and lowest unoccupied molecular orbital (LUMO) in the hydrophobic part of antagonists leads to favorable protein-ligand interactions. Molecular mechanics/generalized born surface area (MM/GBSA) calculations showed that van der Waals and nonpolar solvation energy terms are crucial components for thermodynamically stable binding of the inhibitors. The binding free energy of highly potent compound was found to be ?63.475 kcal/mol; whereas the least active compound exhibited binding energy of ?41.097 kcal/mol. Further, five 100 ns molecular dynamics simulation (MD) simulations were done to confirm the stability of the inhibitor-receptor complex. Outcomes of the present study can serve as the basis for designing improved GCGR antagonists. © 2019 Wiley Periodicals, Inc.
dc.identifier.citationProteins: Structure, Function and Genetics, 2020, 88, 2, pp. 327-344
dc.identifier.issn8873585
dc.identifier.urihttps://doi.org/10.1002/prot.25807
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/24080
dc.publisherJohn Wiley and Sons Inc. P.O.Box 18667 Newark NJ 07191-8667
dc.subjectbeta alanine
dc.subjectG protein coupled glucagon receptor inhibitor
dc.subjectprotein inhibitor
dc.subjectunclassified drug
dc.subjectalanine
dc.subjectamino acid
dc.subjectG protein coupled receptor
dc.subjectglucagon receptor
dc.subjectligand
dc.subjectprotein binding
dc.subjectallosterism
dc.subjectantagonist potency
dc.subjectArticle
dc.subjectbinding site
dc.subjectcrystal structure
dc.subjectdensity functional theory
dc.subjectdrug stability
dc.subjectelectron
dc.subjecthuman
dc.subjecthydrogen bond
dc.subjecthydrophobicity
dc.subjectligand binding
dc.subjectmolecular docking
dc.subjectmolecular dynamics
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectprediction
dc.subjectpriority journal
dc.subjectsolvation
dc.subjectthermodynamics
dc.subjectthree dimensional quantitative structure activity relationship
dc.subjectchemical phenomena
dc.subjectchemistry
dc.subjectenzyme active site
dc.subjectmetabolism
dc.subjectquantitative structure activity relation
dc.subjectAlanine
dc.subjectAmino Acids
dc.subjectBinding Sites
dc.subjectCatalytic Domain
dc.subjectHumans
dc.subjectHydrogen Bonding
dc.subjectHydrophobic and Hydrophilic Interactions
dc.subjectLigands
dc.subjectMolecular Docking Simulation
dc.subjectMolecular Dynamics Simulation
dc.subjectProtein Binding
dc.subjectQuantitative Structure-Activity Relationship
dc.subjectReceptors, G-Protein-Coupled
dc.subjectReceptors, Glucagon
dc.subjectThermodynamics
dc.titleEffect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors

Files

Collections